Chase AIPricingFAQs
Display currency
Loading news…

Point Biopharma

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Indianapolis, Indiana, United States Founded 2017 51-100 employees For Profit

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Point Biopharma was acquired by Eli Lilly in 2023.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
38
Ticker
TXAC
NASDAQ
Patents
7

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
TXAC
Exchange
NASDAQ
IPO date
Jul 8, 2020
Raised at IPO
$118M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Patents granted
7
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9M

Company Info

Founded
2017
Employees
51-100
Operating status
Closed
Company type
For Profit
Org types
company
Founders
2
News articles
67
HQ
Indianapolis, Indiana, United States
Region
Great Lakes, Midwestern US
Exit date
Jul 8, 2020

Signals & Scores

Heat score
Low
Trend (7d)
-0.3
Trend (30d)
-0.9
Trend (90d)
-1.6
Last leadership hire
Jun 21, 2022

Key People at Point Biopharma

EVP, Commercial
38
professional contacts at Point Biopharma
Contact execs at Point Biopharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Point Biopharma

Loading news…

FAQs about Point Biopharma

People who checked this page also checked these

Browse the full Acquirezy directory.
Point Biopharma - Company Profile, Full Acquisitions List, Funding and Investments